Catalyst Wire Dossier Catalyst Wire Dossier

Nexplanon (etonogestrel-releasing implant)

etonogestrel-releasing implant · Merck & Co.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nexplanon (etonogestrel-releasing implant), covering 2024-09-23 to 2024-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant [Phase 4]

See pricing